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Abstract 
   Methicillin-resistant strains of S. aureus evolved in the 1970s and have troubled 
hospitals worldwide with persistent infections in patients. The objectives of this study 
were to determine the prevalence, antimicrobial susceptibility pattern and risk factors 
of MRSA isolated from clinical specimens among military patients at 48 Medical 
Compound in Sana'a city - Yemen. The study included 233 patients of whom 
suffering from Staphylococcus aureus infections. Specimens and data collected from 
November 2016 to November 2017. Standard methods of isolation and identifications 
were used to isolate bacteria in pours culture then Staphylococcus aureus were 
identifying using standard cultural techniques. MRSA was determined by the disc 
diffusion method to oxacillin and antimicrobial susceptibility testing was performed 
by the disc diffusion method for selected antibiotics. The prevalence rate of MRSA 
was 19.3% and there was significant association between MRSA and older age 
patients, and surgical site infections. There was higher rate of antibiotics resistant for 
tested antibiotics in MRSA isolates comparing with lower rate of antibiotics resistant 
in MSSA. 60% of the MRSA isolates were resistant to vancomycin. They were also 
susceptible to erythromycin and rifampicin (100%), but showed resistance to 
Cotrimoxazole and Gentamycine. In conclusion, the emergence of S. aureus isolates 
resistant to vancomycin and other wide range of antibiotics have raised MRSA in 
Yemen into a multi-drug-resistant ‘Superbug”, making it more and more dangerous 
than ever in our hospital environments. Regular surveillance of hospital associated 
infections and monitoring antibiotic sensitivity pattern and strict drug policy for 
antibiotics used within and outside the hospital environments are recommend. 
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Introduction  
 
Staphylococcus aureus (S.aureus) is a bacterium of significant importance 
because of its ability to cause a wide range of diseases and capacity to adapt to diverse 
environmental forms.
1
 The organism colonizes skin, skin glands and mucous 
membrane, causing infections both in human and animals such as rashes, 
inflammations of bones and the meninges as well as septicaemia.
2
 At present, the 
majority of S. aureus strains are resistant to most penicillin derivatives and ordinary 
antimicrobial agents like drugs from the family of aminoglycosides, macrolides, 
chloramphenicol, tetracyclines and fluoroquinolones.
3
 The global spread of MRSA 
constitutes one of the most serious contemporary challenges to the treatment of 
hospital-acquired infections.
4
  MRSA carries a uniquely effective antibiotic resistance 
mechanism that can protect the microorganisms against all members of β-lactam 
antibiotics. This makes infections caused by these pathogens very difficult to manage 
and costly to treat.
5, 6 
The objectives of this study were to determine the prevalence, antimicrobial 
susceptibility pattern and risk factors of MRSA isolated from clinical specimens 
among military patients at 48 Medical Compound in Sana'a city – Yemen 
Subjects and Methods 
Ethical Consideration 
Ethical clearance for the study was taken from the Faculty of Medicine and Health 
Sciences Research Review Committee. A written permission was also taken from the 
administrative Manager of the 48 Medical Compound, Sana'a city, Yemen. Informed 
Consent was taken from the patients before the questionnaire was filled. 
  
Survey procedure and Laboratory Analysis 
This study was conducted during a period of one year, starting in November 2016 and 
ending in November 2017 at 48 Medical compounds in Sana'a city-Yemen. All 
clinical specimens were received and collected by laboratory department of the 
hospital. 233 isolates of S. aureus were isolated from all age groups of out- or 
inpatients hospitalized in different wards. Clinical specimens were taken from various 
body sites of infection including blood, wound, sputum, urine and others. Clinical and 
demographic data were collected for all participants' patients. Clinical specimens were 
collected using standard collection techniques 
7, 8
, and inoculated on appropriate 
bacteriological media, including Blood agar, Chocolate agar, Thioglycollate, Mac-
Conkey Agar Media. The plates were incubated aerobically at 37 °C for 18–24 hours. 
The blood cultures were performed using an automated blood culture system, 
followed by bacterial growth inspection. The identification of isolates was made 
according to standard methods 
9
 for any potential clinically significant growth appear 
on the culture media on the base of quantity, feature of growth, source and site of 
specimens. The primary identification was made with basic microbiological methods 
using colony morphology, Gram staining, catalase and coagulase tests.
7
  Antibiotic 
Resistance Phenotypes (Methicillin/Oxacillin susceptibility testing): All the 
Staphylococcus aureus isolates were tested for the susceptibility to 5 μg Methicillin 
disc and 1 μg Oxacillin disc provided by Difco using the disk diffusion method as 
described by NCCLS. The resistance breakpoints were ≥14 mm to ≤ 10 mm for 5 μg 
Methicillin, and ≥ 12 mm to ≤ 10 mm for 1 μg Oxacillin. The ability of other 
antibiotic disc to inhibit MRSA or MSSA were estimated according to the guidelines 
provided by NCCLS using commercially available discs which include:  
azithromycine (AZM, 15ug), chloramphenicol (C, 30ug), gentamycine (GN, 10ug), 
trimethoprim-sulfamethoxazole (SXT, 1,25/23,75ug), Oxacillin (OX, 1ug), 
erythromycin (E, 15ug), cefoxitin (FOX, 30ug), nitrofurantoin (NIT, 300ug), 
tetracycline (T, 30ug), teicoplanin (TE, 30ug), clindamycin (CC, 2ug), rifampicin 
(RA, 5ug), ciprofloxacin (5 µg, Ci), vancomycin (V, 30ug) and others listed in table 
4. 
Data analysis 
The analysis of data was done by Epi Info version 6 statistical program (CDC, 
Atlanta, USA), where the chi-square (χ2) and probability value (p) was calculated for 
the test of significance. In addition, Odd's ratio (OR), confidence interval (CI) were 
added to estimate the risk factors of contracting MRSA. 
Results  
Tables 1, 2, 3 show the prevalence of MSSA and MRSA among isolated coagulase 
positive (S. aureus), the potential associated factors of MRSA in patients with 
S.aureus infection and the association between prevalence of MRSA and type of 
hospital wards. Also, the susceptibility pattern of S. aureus strains is presented in 
table 4. The prevalence rate of MRSA was 19.3% and there was significant 
association between MRSA and older age patients, and surgical site infections. There 
was higher rate of antibiotics resistant for tested antibiotics in MRSA isolates 
comparing with lower rate of antibiotics resistant in MSSA. Also, 60% of the MRSA 
isolates were resistant to vancomycin. They were also susceptible to erythromycin and 
rifampicin (100%), but showed resistance to Cotrimoxazole and Gentamycine. 
Discussion 
We detected MRSA in 19.3% of all staphylococcus aureus isolates (table 1).   
Our result is lower than that reported from USA in which MRSA was isolated from 
59% of patients with skin and soft tissue infections.
10
  Also our  19.3% MRSA of all 
staphylococcus aureus isolates is lower than that reported from Yemen in previous 
reports in which MRSA was isolated from 55% of HCWs in Taiz city, Yemen
11
 and 
extremely low from that reported by Al-Baidani et al, 
12
 among HCWs in Hodeida 
city, Yemen in which the MRSA rate was 86% . In addition, the prevalence of MRSA 
among our inpatients (HA-MRSA) was 19.4% roughly similar to 19.2% among 
  
outpatients (CA-MRSA) (table .2). Prolonged hospital stays, indiscriminate use of 
antibiotics, lack of awareness, and receipt of antibiotics before coming to the hospital 
are some of the possible predisposing factors of MRSA emergence in the hospital and 
community. Our result is different from that reported from USA in which high rate of 
MRSA was occurred in hospital acquired S. aureus infections (HA-MRSA) (59%), 
than in community acquired infection S.aureus (17%).
13
  This variation can be 
explained by that the biology of CA-MRSA appears to differ from that of HA-MRSA 
and CA–Methicillin-susceptible S. aureus (MSSA), perhaps allowing CA-MRSA to 
cause disease other than that expected from MSSA.
14,15
 As HA-MRSA emerged, it 
likely did not merely replace HA-MSSA but led to an overall increase in S. aureus 
infections in healthcare settings.
16,17
  In addition nearly all the researchers say the 
same thing that in-patients and out-patients have higher  S. aureus/MRSA infections 
than S. aureus / MSSA because of wide spread of MRSA in community and hospitals 
environment.
17, 18,19
   
     When we considered age as risk factor of MRSA in our study, the highest 
incidence of MRSA in  our cases were in  age groups of  > median (24 years).  The 
risk age group of in-patients and out-patients in our study was different from that 
reported previously in several studies in which roughly equal rates of MRSA in the 
different age groups.
20
. In our study when we considered the association between 
prevalence of MRSA and sites of infections (type of clinical specimens), the highest 
prevalence MRSA was 33.3% in surgical site infection (SSI) with associated odds 
ratio equal to 2.2 (P>= 0.05) (table 2). The general pattern of MRSA  infections in this 
study  is not different from that worldwide in which in MRSA in surgical site 
infection (SSI)  was one of the major diagnosis infections by MRSA
.20
   
We carried this study because of the knowledge of MRSA prevalence and the 
current antimicrobial profile is necessary in selection of appropriate empirical 
treatment of these infections and control of MRSA in hospitals is essential. In our 
study vancomycin resistant was 40% in isolated MRSA. This result is different from 
that reported in Asian countries in which the rate of vancomycin resistant was not 
more than 10%.
21
 Also the incidence of VRSA in the Asian  countries has been 
documented  by Kaleem et al, 
22
 in Pakistan to be 3.3% ,  6% in India, by Sonavane  
and  Mathur 
23
,   7.5%  in Iran by Mehdinejad  et al,
24
, and 9% in Jordan by Al-Zoubi 
et al,.
3
 
The results of our study shows a higher rate of resistant of MRSA comparing 
with a study carried out at India in 2009 which showed variable susceptibility pattern 
with high resistance rates to tetracycline (82%), clindamycin (79%), and 
cotrimoxazole (59%), while in our study all MRSA were sensitive to rifampicin 
different to 50% of rifampicin resistant in India.
25
  On other hand resistance to 
chloramphenicol (50%) and naldixic acid (50%) was lower than Indian studies in 
which resistance to chloramphenicol was10% and naldixic acid was 9%.
25 
 Studies 
carried out at by Kishore et al, 
26
 in India, by Kaleem et al, 
22
 in Pakistani and by Al-
Zoubi et al, 
3 
in Jordan showed that less than 10% of MRSA isolates were sensitive to 
Macrolides, whereas 38% of isolates were found to be sensitive in our study. In our 
study 100% of the MRSA isolates were sensitive to ciprofloxacin which is 
harmonized with the results of  India , Pakistani, Iranian and Jordan studies  in which 
ciprofloxacin also found to be 100% sensitive to all MRSA isolates.
3,22,26, 27
 Effective 
antimicrobial activity as well as cost effectiveness should be considered in drugs 
prescribed for MRSA infections. Oral dosing options for antibiotics can allow earlier 
discharge of hospitalized patients and minimize the chances of VRSA emergence. 
Good hospital infection control measures prove to be the main stay against these 
infections because antibiotics can never be an effective alternative to good medical 
practice. Also, medium sensitivity percentages were found to gentamycine, 
trimethoprim-sulfamethoxazole and tetracycline (Table 4). Different sensitivity 
percentages have been reported to these three antibiotics worldwide
. 28, 29, 30
 These 
differences might be due to prolonged antibiotic treatment, age, type of infection and 
geographical variation. 
 
 
  
Conclusions 
In conclusion, the results of this study showed the importance of regular surveillance 
of hospital associated infections including monitoring antibiotic sensitivity pattern 
and strict drug policy for antibiotics used within and outside the hospital 
environments. Moreover, in-vitro susceptibility testing of every isolate of MRSA in 
the clinical laboratories may be helpful for reducing the incidence of these infections. 
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Table 1 : The prevalence of MSSA and MRSA among isolated coagulase positive (S. 
aureus) in Sana'a city, 2017 
 
Organisms Number 
 
Percentage 
 
MSSA 188 80.7 
MRSA 45 19.3 
Total Staphylococcus aureus 233 100 
 
Table 2: The potential associated risk factors of  MRSA in patients with S.aureus 
infection in Sana'a city, 2017 
 
 
 
Factors 
MRSA MSSA  
OR 
 
CI 
 
2 
 
p 
No. % No. % 
In-patients n=103 20 19.4 83 80.6 1.0 0.5-1.97 0.001 0.97 
Out-patients n=130 25 19.2 105 80.8 0.98 0.5-1.9 0.001 0.97 
Age Median (24 years) 
<24 years 
     n=104 
13 12.5 89 85.6 0.45 0.23-0.9 5 0.02 
>24 years 
n=129 
32 24.8 99 76.7 2.2 1.1-4.5 5 0.02 
Clinical specimens 
Surgical wound pus  
n=39 
9 23.1 30 76.9 1.3 0.6-3.2 0.6 0.43 
Nonsurgical wounds pus  
n=77 
13 16.9 64 83.1 0.78 0.36-1.6 0.43 0.51 
Pleural fluid n=5 1 20 4 80 1.04 0.11-9.5 0.002 0.96 
Sputum  n=23 3 13 20 87 0.6 0.17-2.1 0.64 0.42 
Surgical site infections (SSI) 
Wound and pus  n=21 
7 33.3 14 66.7 2.3 1.0-6 3.9 0.05 
Urine culture  n=41 6 14.6 35 85.4 0.67 0.26-1.7 0.69 0.4 
Bone pus  n=27 6 22.2 21 77.8 1.2 0.46-3.2 0.16 0.68 
OR          Odds ratio >1 (at risk) 
CI           Confidence intervals  
 χ 2         Chi-square ≥3.9 (significant) 
 p             Probability value ≤0.05 (significant) 
 
  
Table 3: The association between prevalence of MRSA and type of hospital wards in 
Sana'a city. 
 
 
In-patients Wards 
MRSA MSSA  
OR 
 
CI 
 
2 
 
p v 
No. % No. % 
Orthopedic ward 
n=34 (33%) 
7 20.6 27 79.4 1.1 0.39-3.1 0.031 0.86 
Urology wards 
n=14 (13.5%) 
4 28.6 10 71.4 1.5 0.45-5.1 0.37 0.59 
Internal Medical 
wards   
n=7 (6.8%) 
1 14.3 6 85.7 0.67 0.07-5.9 0.12 0.72 
Surgical wards 
n=48 (46.6%) 
8 16.7 40 83.3 0.56 0.2-1.5 1.3 0.25 
OR          Odds ratio >1 (at risk) 
CI           Confidence intervals  
 χ 2         Chi-square ≥3.9 (significant) 
 p             Probability value ≤0.05 (significant) 
 
Table 4: The antibiotic sensitivity for isolated  MRSA and MSSA for tested antibiotics in Sana'a city. 
 
 
Antibiotics 
MRSA  
n=45 
MSSA  
n=188 
% Sensitive % Resistant % Sensitive % Resistant 
Azithromycin 66.7 33.3 60.9 39.1 
Carbinicillin 0 100 100 0 
Cefotaxime 25 75 61 39 
Cefepime 44.4 55.6 65.6 34.4 
Ceftazidime 50 50 50 50 
Ceftriaxone 100 0 61.2 34.8 
Cefalexin 49 51 76.3 23.7 
Nalidixic acid 50 50 46.7 53.3 
Chloramphenicol 50 50 66.7 33.3 
Ciprofloxacin 100 0 61.3 38.7 
Clindamycin 0 100 33.3 66.7 
Cotrimoxazole 0 100 80 20 
Erythromycin 100 0 65.6 34.4 
Gentamicin 50 50 87.5 12.5 
Nitrofurantoin 0 100 71.4 28.6 
Rifampicin 100 0 33.3 76.7 
Tetracycline 40 60 22.2 77.8 
Ticarcillin 42.9 57.1 9.5 90.5 
Tobramycin 55 45 30 70 
Vancomycin 60 40 20 80 
 
 
